|
Name |
Methyl hexanoate
|
Molecular Formula | C7H14O2 | |
IUPAC Name* |
methyl hexanoate
|
|
SMILES |
CCCCCC(=O)OC
|
|
InChI |
InChI=1S/C7H14O2/c1-3-4-5-6-7(8)9-2/h3-6H2,1-2H3
|
|
InChIKey |
NUKZAGXMHTUAFE-UHFFFAOYSA-N
|
|
Synonyms |
METHYL HEXANOATE; Methyl caproate; 106-70-7; Hexanoic acid, methyl ester; Hexanoic Acid Methyl Ester; Methyl hexoate; Methyl n-hexanoate; Methyl capronate; Methyl hexylate; Caproic acid methyl ester; FEMA No. 2708; Methyl n-hexoate; NSC 5023; Caproic acid, methyl ester; n-Caproic acid methyl ester; Methyl ester of hexanoic acid; HEXANOIC ACID,METHYL ESTER; 246364VPJS; NSC-5023; WE(1:0/6:0); Methyl caproate (natural); EINECS 203-425-1; BRN 1744683; methylcaproate; UNII-246364VPJS; Hexanoic acid methyl; MFCD00009510; Methyl hexanoate, 99%; hexanoic acid-methyl ester; EC 203-425-1; SCHEMBL124681; METHYL CAPROATE [INCI]; METHYL HEXANOATE [FCC]; METHYL HEXANOATE [FHFI]; DTXSID0047616; CHEBI:77322; FEMA 2708; METHYL CAPROATE [USP-RS]; Methyl hexanoate, >=99%, FG; NSC5023; ZINC1680660; LMFA07010433; Methyl hexanoate, analytical standard; STL453686; AKOS000121260; Methyl hexanoate, natural, >=99%, FG; LS-13339; FT-0628711; H0111; S0304; EN300-15456; A801486; J-001632; Q3135043; 338DD8BE-299B-44EE-816C-16C9BDD20EC6; Hexanoic acid-methyl ester 1000 microg/mL in n-Hexane; Methyl hexanoate, certified reference material, TraceCERT(R); Methyl caproate, United States Pharmacopeia (USP) Reference Standard
|
|
CAS | 106-70-7 | |
PubChem CID | 7824 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 130.18 | ALogp: | 2.5 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 9 | QED Weighted: | 0.431 |
Caco-2 Permeability: | -4.321 | MDCK Permeability: | 0.00003030 |
Pgp-inhibitor: | 0.016 | Pgp-substrate: | 0.019 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.038 |
30% Bioavailability (F30%): | 0.723 |
Blood-Brain-Barrier Penetration (BBB): | 0.997 | Plasma Protein Binding (PPB): | 53.67% |
Volume Distribution (VD): | 0.78 | Fu: | 56.38% |
CYP1A2-inhibitor: | 0.928 | CYP1A2-substrate: | 0.767 |
CYP2C19-inhibitor: | 0.426 | CYP2C19-substrate: | 0.823 |
CYP2C9-inhibitor: | 0.135 | CYP2C9-substrate: | 0.787 |
CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.223 |
CYP3A4-inhibitor: | 0.033 | CYP3A4-substrate: | 0.206 |
Clearance (CL): | 9.673 | Half-life (T1/2): | 0.85 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.047 |
Drug-inuced Liver Injury (DILI): | 0.129 | AMES Toxicity: | 0.012 |
Rat Oral Acute Toxicity: | 0.061 | Maximum Recommended Daily Dose: | 0.031 |
Skin Sensitization: | 0.646 | Carcinogencity: | 0.253 |
Eye Corrosion: | 0.962 | Eye Irritation: | 0.978 |
Respiratory Toxicity: | 0.203 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000253 | 0.800 | D01QLH | 0.394 | ||||
ENC000249 | 0.667 | D0OL6O | 0.389 | ||||
ENC000250 | 0.607 | D0AY9Q | 0.347 | ||||
ENC001036 | 0.606 | D09ANG | 0.307 | ||||
ENC000260 | 0.571 | D0FD0H | 0.297 | ||||
ENC001253 | 0.559 | D0ZI4H | 0.288 | ||||
ENC000228 | 0.556 | D0Y3KG | 0.282 | ||||
ENC000315 | 0.552 | D0G2KD | 0.246 | ||||
ENC001025 | 0.548 | D0UE9X | 0.246 | ||||
ENC000254 | 0.548 | D03XTC | 0.242 |